Interactions between Cytosolic Phospholipase A2 Activation and Mitochondrial Reactive Oxygen Species Production in...

Area of Science:

• Physiology
• Biochemistry
• Cell Biology

Background:

• Cytosolic phospholipase A2 (cPLA2) is implicated in infection-related mitochondrial reactive oxygen species (ROS) production and diaphragm dysfunction (DD).
• Ventilator-induced diaphragm dysfunction (VIDD) is a significant clinical concern.
• The role of cPLA2 in VIDD remains largely unexplored.

Purpose of the Study:

• To investigate the involvement of cPLA2 in the development of ventilator-induced diaphragm dysfunction (VIDD).
• To elucidate the relationship between cPLA2 activation, mitochondrial ROS generation, and diaphragm function during mechanical ventilation.

Main Methods:

• Mechanical ventilation (MV) was applied to assess diaphragm function, cPLA2 activation, and mitochondrial ROS levels.
• Specific cPLA2 inhibition using CDIBA and a mitochondria-targeted antioxidant (MitoTEMPO) were employed.
• Protein degradation, muscle atrophy, and tissue perfusion were evaluated.
• In vitro studies using C2C12 cells under hypoxic conditions were conducted.

Main Results:

• Mechanical ventilation induced cPLA2 activation, excessive mitochondrial ROS, and diaphragm muscle weakness.
• Inhibition of cPLA2 with CDIBA reduced mitochondrial ROS and improved diaphragm forces.
• MitoTEMPO attenuated oxidative stress and cPLA2 activation, mitigating muscle atrophy and weakness.
• MV decreased diaphragm tissue perfusion, leading to hypoxia, which positively correlated with cPLA2 activation and ROS generation in vitro.

Conclusions:

• cPLA2 activation is a key mediator in the development of VIDD, closely interacting with mitochondrial ROS generation.
• Ventilator-induced diaphragm hypoxia may contribute to a positive feedback loop involving cPLA2 and mitochondrial ROS.
• Targeting cPLA2 or mitochondrial ROS presents a potential therapeutic strategy for preventing or treating VIDD.